Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive Prophylaxis with Azithromycin and Hydroxychloroquine in Patients Hospitalized with COVID-19
2020-001198-55Phase 2Terminated
- Sponsor
- COPD360Net
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of azithromycin and hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by COPD360Net. Primary endpoint: Days alive and discharged from hospital within 14 days. Started Mar 2020; status: terminated.
02
Drugs
azithromycinhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001198-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001198-55.